Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06907706 · ClinicalTrials.gov registry record · NA

Active Living After Cancer: Implementation Within Be Well Acres Homes

A NA study of Cancer and Fatigue, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
164
Enrollment target
1
Study location

NCT06907706: Recruiting NA study of Cancer and Fatigue, sponsored by M.D. Anderson Cancer Center.

NCT06907706 is a NA study of Cancer and Fatigue that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 164 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06907706, a NA study of Cancer and Fatigue, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to learn more about a physical activity program adapted for cancer survivors.

Primary Outcome

1\. Physical functioning change from baseline to 12 weeks, as measured by the 30-second sit-to-stand test

Conditions Studied

Interventions

  • BEHAVIORAL Physical Activity/Physical Functioning
  • BEHAVIORAL Quality of Life

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2023-04-03
Est. Completion 2029-04-30
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What NCT06907706 shows while recruiting

NCT06907706 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity/Physical Functioning is the first listed.

NCT06907706 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06907706 about?

NCT06907706 is a clinical study titled "Active Living After Cancer: Implementation Within Be Well Acres Homes". The goal of this research study is to learn more about a physical activity program adapted for cancer survivors.

What is the current status of trial NCT06907706?

This trial is currently recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2023-04-03. Estimated completion is 2029-04-30.

What conditions does trial NCT06907706 study?

This clinical trial studies the following conditions: Cancer, Fatigue.

What interventions are being tested in trial NCT06907706?

The interventions under investigation include: Physical Activity/Physical Functioning (BEHAVIORAL), Quality of Life (BEHAVIORAL).

Who is sponsoring clinical trial NCT06907706?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06907706 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06907706's enrollment target sits among peer trials

164 258th of 615 higher than 358 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04891289 · 164 participants · Phase 2

    Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

  • NCT04893226 · 164 participants · NA

    Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

  • NCT05270213 · 164 participants · Phase 1

    Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

  • NCT05543681 · 164 participants · Phase 2

    Clinical Trial on Agitation in Alzheimer's Dementia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06907706, the US trial registry maintained by the National Library of Medicine. NCT06907706 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.